AUTL AUTOLUS THERAPEUTICS PLC Earnings Reports 8-K Filing 2023 - ASH Annual Meeting Presentation Autolus Therapeutics announced oral presentations and posters at the ASH Annual Meeting, including data from clinical studies and pre-clinical data on a CAR T cell candidate.Get access to all SEC 8-K filings of the AUTOLUS THERAPEUTICS PLC